Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enovix (ENVX) Current Deferred Revenue (2020 - 2025)

Enovix (ENVX) has disclosed Current Deferred Revenue for 6 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 45.21% year-over-year to $5.3 million, compared with a TTM value of $5.3 million through Dec 2025, up 45.21%, and an annual FY2025 reading of $5.3 million, up 45.21% over the prior year.
  • Current Deferred Revenue was $5.3 million for Q4 2025 at Enovix, down from $8.0 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $10.8 million in Q2 2024 and bottomed at $350000.0 in Q3 2023.
  • Average Current Deferred Revenue over 5 years is $6.1 million, with a median of $5.5 million recorded in 2021.
  • The sharpest move saw Current Deferred Revenue plummeted 87.93% in 2023, then skyrocketed 2985.71% in 2024.
  • Year by year, Current Deferred Revenue stood at $5.5 million in 2021, then fell by 21.75% to $4.3 million in 2022, then soared by 143.77% to $10.5 million in 2023, then crashed by 65.18% to $3.6 million in 2024, then surged by 45.21% to $5.3 million in 2025.
  • Business Quant data shows Current Deferred Revenue for ENVX at $5.3 million in Q4 2025, $8.0 million in Q3 2025, and $8.4 million in Q2 2025.